🚨 A new cancer vaccine appears to significantly improve survival in people in remission from acute myeloid leukemia (AML), according to new results from a phase 3 clinical trial.
The vaccine, galinpepimut-S (GPS), is an “off-the-shelf” vaccine invented by MSK leukemia specialist and physician-scientist Dr. David A. Scheinberg (@DASLab_MSKCC). In the trial of 126 patients, it reduced the risk of death by 41%. Median overall survival was 24.0 months with the vaccine compared with 14.7 months for patients on standard treatments.
“These data bring us closer to having the first off-the-shelf vaccine for AML patients." Learn more: bit.ly/4fDoAmS
Register by December 2 to get the lowest rates for the AACR Conference on Cancer Biology-informed Radioligand Therapy (Jan 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
brnw.ch/21x6Ihk#aacrRLT27@KeshariLab
Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
brnw.ch/21x6y52#aacrRLT27@KeshariLab
This work started when Andrew Cho joined the lab, asking if we could leverage arginine metabolism for in vivo metabolic tracing, building some really interesting findings. Stay tuned for where ornithine goes next…
Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
brnw.ch/21x5XW9#aacrRLT26@KeshariLab
Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
brnw.ch/21x5qeO#aacrRLT26@KeshariLab
Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
brnw.ch/21x5caV#aacrRLT26@juliesut8
Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
brnw.ch/21x4QzA#aacrRLT26@KeshariLab
Congrats to Briana for defending her PhD, so many amazing directions all coming together! Especially being able to bridge @KeshariLab and @KharasLab. We are looking forward to the things you do next.
Submit an abstract by October 21 for the AACR Special Conference on Cancer Biology-informed Radioligand Therapy (January 7-10; San Diego), chaired by Kayvan Keshari, David Piwnica-Worms, Julie L. Sutcliffe, and David A. Tuveson.
brnw.ch/21x4hB6#aacrRLT26@KeshariLab
We are looking for a motivated Post-doctoral scholar to really push the envelope in metabolic imaging. Come join our group at MSK!
linkedin.com/posts/kayvan-r-…